Showing 1 - 4 of 4
Many medical studies collect biomarker data to gain insight into the biological mechanisms underlying both acute and chronic diseases. These markers may be obtained at a single point in time to aid in the diagnosis of an illness or may be collected longitudinally to provide information on the...
Persistent link: https://www.econbiz.de/10009428805
Longitudinal censoring is a common artifact when evaluating biomarkers and an obstacle to overcome when jointly investigating the longitudinal nature of the data and the impact on the survival prognoses of a study population. To fully appreciate the complexity of this scenario one has to devise...
Persistent link: https://www.econbiz.de/10009428845
In a longitudinal study of biomarker data collected during a hospital stay, observations may be missing due to administrative reasons, the death of the subject or the subject's discharge from the hospital, resulting in non-ignorable missing data. Standard likelihood-based methods for the...
Persistent link: https://www.econbiz.de/10009428913
Survival analysis has been used to estimate underlying survival or failure probabilities and to estimate the effects of covariates on survival times. The Cox proportional hazards regression model is the most commonly used approach. However, in practical situations, the assumption of proportional...
Persistent link: https://www.econbiz.de/10009428920